Drugs@FDA document
NOVOLOG Letter · BLA 020986 SUPPL-95
Drugs@FDA document · NOVO NORDISK INC · Nov 2, 2022
Key facts
| Drug name | NOVOLOG |
|---|---|
| Document type | Letter |
| Application | BLA020986 |
| Submission | SUPPL-95 |
| Company | NOVO NORDISK INC |
| Document date | Nov 2, 2022 |
| FDA document | accessdata.fda.gov |
At a glance
- Manufacturing (CMC)-Manufacturing Process Document categories
- 100–999 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: